Inhibikase Therapeutics, Inc. [IKT]

Source: 

Company Overview

Inhibikase Therapeutics, Inc is a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson’s disease (“PD”), Parkinson’s-related disorders and other diseases of the Abelson Tyrosine Kinases.